+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of pindolol absorption in malabsorption syndromes



Evaluation of pindolol absorption in malabsorption syndromes



Gastroenterologie Clinique et Biologique 7(4): 398-404



Reports on drug absorption in intestinal diseases are scarce. To investigate pindolol absorption, a drug particularly well absorbed and with low hepatic extraction, plasma concentrations and 54-h urinary excretion (after both oral and intravenous dose) were studied in 6 healthy volunteers and 13 patients with intestinal malabsorption (coeliac disease 5 cases, short bowel syndrome 8 cases) after an overnight fasting. Pindolol plasma concentrations were almost identical after a single intravenous dose in both patients and controls. Again mean blood levels after an unique oral dose were not significantly different between the two groups. However, absorption was slow and/or delayed in eight out of thirteen patients and overall absorption was decreased in two of them. These abnormalities might be related to the diseased intestine, since plasma concentrations and urinary excretion following intravenous administration were quite similar to those observed in volunteers. Nevertheless, results were not related to the extent of the intestinal disease nor the degree of impairment of small intestinal function.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 043048965

Download citation: RISBibTeXText

PMID: 6873552


Related references

Study of the bioavailability of pindolol in malabsorption syndromes. British Journal of Clinical Pharmacology 18(4): 632-637, 1984

Dynamic status of the small intestine in the absorption process. II. Present concept and physiopathology of intestinal absorption. General classification of malabsorption syndromes. Revista Da Associacao Medica Brasileira 11(4): 140-158, 1965

Absorption Of Copper In Malabsorption Syndromes. Journal of Clinical Investigation 43: 1049-1055, 1964

Copper absorption in malabsorption syndromes. Jour Clin Invest 42(6): 984, 1963

The d-xylose absorption test in malabsorption syndromes. New England Journal of Medicine 256(8): 335-339, 1957

A study of absorption patterns in malabsorption syndromes. Acta Medica Scandinavica 168: 117-125, 1960

Digoxin absorption in malabsorption syndromes of various etiology. Orvosi Hetilap 120(25): 1507-1509, 1979

Absorption of digoxin in patients with malabsorption syndromes. New England Journal of Medicine 285(5): 257-259, 1971

Mal-absorption syndromes A symposium. I. Classification of malabsorption syndrome. Brit Jour Radiol 33(388): 201-211, 1960

Absorption of digoxin from tablets and capsules in subjects with malabsorption syndromes. Dicp 23(10): 764-769, 1989

Absorption of two antibacterial drugs, cephalexin and co-trimoxazole, in malabsorption syndromes. Journal of Antimicrobial ChemoTherapy 1(3 Suppl): 59-67, 1975

Correlation of various absorption tests and their utility in the diagnosis of malabsorption syndromes. Journal of the Association of Physicians of India 18(6): 539-550, 1970

Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes. Clinical Pharmacokinetics 2(1): 45-60, 1977

Apropos of Carbohydrate Malabsorption Syndromes. the Absorption-Digestion of Lactose. Revue Medicale de la Suisse Romande 84: 653-663, 1964

Tritiated digoxin. XXII. Absorption and excretion in malabsorption syndromes. American Journal of Medicine 56(4): 437-442, 1974